Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Working Capital/Sales

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 19.7210.9116.1614.8621.57

What is the latest Working Capital/Sales ratio of BAL PHARMA ?

The latest Working Capital/Sales ratio of BAL PHARMA is 19.72 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar202519.72
Mar202410.91
Mar202316.16
Mar202214.86
Mar202121.57

How is Working Capital/Sales of BAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 19.72
80.75
Mar2024 10.91
-32.49
Mar2023 16.16
8.75
Mar2022 14.86
-31.11
Mar2021 21.57 -

Other Financial Ratios of BAL PHARMA


Compare Working Capital/Sales ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹119.3 Cr 4.8% 4.4% -9.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

4.8%

4.4%

-9.4%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses